Molecular Partners AG (XSWX:MOLN) Pre-Tax Income : CHF-61.98 Mil (TTM As of Dec. 2023)

View and export this data going back to 2014. Start your Free Trial

What is Molecular Partners AG Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. Molecular Partners AG's pretax income for the three months ended in Dec. 2023 was CHF-19.78 Mil. Its pretax income for the trailing twelve months (TTM) ended in Dec. 2023 was CHF-61.98 Mil. Molecular Partners AG's pretax margin was -1,916.67%.

During the past 11 years, Molecular Partners AG's highest Pretax Margin was 62.17%. The lowest was -880.71%. And the median was -152.50%.

Molecular Partners AG Pre-Tax Income Historical Data

The historical data trend for Molecular Partners AG's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Molecular Partners AG Pre-Tax Income Chart

Molecular Partners AG Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Pre-Tax Income

Get a 7-Day Free Trial

-36.27

-62.78

-63.78

117.85

-61.98

Molecular Partners AG Quarterly Data
	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Pre-Tax Income	Get a 7-Day Free Trial															-17.43	-14.78	-15.99	-11.44	-19.78

Competitive Comparison of Molecular Partners AG's Pre-Tax Income

For the Biotechnology subindustry, Molecular Partners AG's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Molecular Partners AG's Pre-Tax Income Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Molecular Partners AG's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Molecular Partners AG's Pre-Tax Income falls into.

Molecular Partners AG Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Molecular Partners AG's Pretax Income for the fiscal year that ended in Dec. 2023 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	-61.108	+	-5.106	+	-0.034	+	4.279	+	-0.015000000000008
	=	-61.98

Molecular Partners AG's Pretax Income for the quarter that ended in Dec. 2023 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	-16.648	+	-4.255	+	-0.008	+	1.134	+	-0.0030000000000037
	=	-19.78

Pre-Tax Income for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was CHF-61.98 Mil.

Molecular Partners AG (XSWX:MOLN) Pre-Tax Income Explanation

Molecular Partners AG's Pretax Margin for the quarter that ended in Dec. 2023 is calculated as

Pretax Margin	=	Pretax Income	/	Revenue
	=	-19.78	/	1.032
	=	-1,916.67%

During the past 11 years, Molecular Partners AG's highest Pretax Margin was 62.17%. The lowest was -880.71%. And the median was -152.50%.

Molecular Partners AG Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Molecular Partners AG's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Molecular Partners AG (XSWX:MOLN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Molecular Partners AG (XSWX:MOLN) » Definitions » Pre-Tax Income

Comparable Companies

Traded in Other Exchanges

MOLN:USA MLLCF:USA MOLNz:UK 6ML0:Germany

Address

Wagistrasse 14, Schlieren, Zurich, CHE, 8952

Website

https://www.molecularpartners.com

Molecular Partners AG is a clinical stage biopharmaceutical company. The company focuses on the discovery, development and prospective commercialization of a new class of biopharmaceutical products. The firm develops protein therapeutics called DARPin therapeutics for the treatment of serious diseases, including cancer and sight-threatening disorders. The company's product pipeline is organized principally through three areas: Ophthalmology, including the creation of therapies for retinal diseases like wet age-related macular degeneration and diabetic macular edema; the Oncology pipeline comprises DARPin candidates with novel modes of action, including multi-DARPin compounds; and Immuno-oncology for anticancer treatment.